z-logo
open-access-imgOpen Access
Altered Plasma Versus Vascular Biopterins in Human Atherosclerosis Reveal Relationships Between Endothelial Nitric Oxide Synthase Coupling, Endothelial Function, and Inflammation
Author(s) -
Charalambos Antoniades,
Cheerag Shirodaria,
Mark J. Crabtree,
Ruth Rinze,
Nicholas Alp,
Colin Cunnington,
Jonathan Diesch,
Dimitris Tousoulis,
Christodoulos Stefanadis,
Paul Leeson,
C Ratnatunga,
Ravi Pillai,
Keith M. Chan
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.704155
Subject(s) - medicine , enos , tetrahydrobiopterin , endocrinology , nitric oxide , biopterin , superoxide , nitric oxide synthase type iii , endothelial dysfunction , endothelium , nitric oxide synthase , vascular disease , chemistry , biochemistry , enzyme
Tetrahydrobiopterin (BH4) is a key regulator of endothelial nitric oxide synthase (eNOS) activity and coupling. However, the extent to which vascular and/or systemic BH4 levels are altered in human atherosclerosis and the importance of BH4 bioavailability in determining endothelial function and oxidative stress remain unclear. We sought to define the relationships between plasma and vascular biopterin levels in patients with coronary artery disease and to determine how BH4 levels affect endothelial function, eNOS coupling, and vascular superoxide production.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom